Cargando…

New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives Dave Singh

Fixed dose combination (FDC) dual bronchodilators that co-administer a long acting β(2)-adrenoceptor agonist (LABA) and a long acting muscarinic antagonist (LAMA) are a new class of inhaled treatment for chronic obstructive pulmonary disease (COPD). This review focuses on the clinical evidence for t...

Descripción completa

Detalles Bibliográficos
Autor principal:	Singh, Dave
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415707/ https://www.ncbi.nlm.nih.gov/pubmed/25377687 http://dx.doi.org/10.1111/bcp.12545

Ejemplares similares

Dave Sperling's Internet guide.
por: Sperling, Dave
Publicado: (1998)

Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2013)

The Dave Brubeck Quartet
Publicado: (1950)

Dave Barney, CMS physicist
Publicado: (2007)

A Conversation with Shreya Dave
por: Katsnelson, Alla
Publicado: (2018)

Response to Singh and Singh
por: Calder, Philip C.
Publicado: (2022)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
por: Asche, Carl Victor, et al.
Publicado: (2012)

Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
por: Ramadan, Wijdan H, et al.
Publicado: (2015)

The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease
por: Beeh, Kai M.
Publicado: (2016)

The future of bronchodilation: looking for new classes of bronchodilators
por: Cazzola, Mario, et al.
Publicado: (2019)

ATLAS Management: Spokesperson Dave Charlton and Deputies
por: Brice, Maximilien
Publicado: (2016)

Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease
por: van der Vaart, Hester, et al.
Publicado: (2011)

Translation process of six short stories by Dave Eggers. /
por: Domínguez Hernández, Karina Guadalupe
Publicado: (2014)

New Perspectives on Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome R, et al.
Publicado: (2022)

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
por: Donohue, James F, et al.
Publicado: (2011)

Nadia Singh
por: Marwaha, Seema
Publicado: (2021)

Design of a "Digital Atlas Vme Electronics" (DAVE) Module
por: Goodrick, M., et al.
Publicado: (2011)

Future concepts in bronchodilation for COPD: dual- versus monotherapy
por: Singh, Dave, et al.
Publicado: (2021)

Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007)

Severity Staging of Chronic Obstructive Pulmonary Disease: Differences in Pre- and Post-Bronchodilator Spirometry
por: Lin, Sheng-Hsiang, et al.
Publicado: (2009)

The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G.
Publicado: (2018)

The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease
por: Shin, Hong-Joon, et al.
Publicado: (2021)

MANJEET SINGH PRIZE
Publicado: (2015)

Dr. Hardyal Singh
Publicado: (2016)

Harmit Singh Malik
por: Grow, Adri K
Publicado: (2022)

A Conversation with Ashok Kumar Singh
por: Chawla, Dalmeet Singh
Publicado: (2022)

Dave Barney of CMS with the Outreach Prize awarded by the European Physical Society
Publicado: (2005)

eDAVE – Extension of GDC data analysis, visualization, and exploration tools
por: Bińkowski, Jan, et al.
Publicado: (2023)

The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease
por: Kliber, Agnes, et al.
Publicado: (2010)

Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease
por: Pisi, Roberta, et al.
Publicado: (2015)

Role of the Bronchodilator Test Defined by the Forced Vital Capacity in Chronic Obstructive Pulmonary Disease Phenotyping
por: Zhang, Xiaoling, et al.
Publicado: (2020)

Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment
por: Cheng, Shih-Lung
Publicado: (2021)

Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease
por: Leaker, Brian R., et al.
Publicado: (2019)

Letter in response to letter to the editor by Singh and Dhibar regarding the article “COVID-19: From bench to bedside” (Singh et al.)
por: Singh, Akriti, et al.
Publicado: (2020)

Conference held in Memory of U. N. Singh
por: Yadav, B, et al.
Publicado: (1992)

Pocket Singh: Periodontist of the year
por: Arunachalam, D.
Publicado: (2009)

PROF. MANJEET SINGH PRIZE
Publicado: (2014)

COLONEL KRIPAL SINGH AWARD
Publicado: (2018)

Prof. Kuldeep Singh Goleria
por: Thatte, Ravin, et al.
Publicado: (2017)

First person – Pratibha Singh
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jin2mev4pa8rckfsbtcjbv0op7